{"id":240561,"date":"2026-07-09T20:06:45","date_gmt":"2026-07-10T01:06:45","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/07\/human-safe-drug-repairs-dna-in-a-mouse-model-of-alzheimers"},"modified":"2026-07-09T20:06:45","modified_gmt":"2026-07-10T01:06:45","slug":"human-safe-drug-repairs-dna-in-a-mouse-model-of-alzheimers","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/07\/human-safe-drug-repairs-dna-in-a-mouse-model-of-alzheimers","title":{"rendered":"Human-safe drug repairs DNA in a mouse model of Alzheimer\u2019s"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/human-safe-drug-repairs-dna-in-a-mouse-model-of-alzheimers2.jpg\"><\/a><\/p>\n<p>While most current Alzheimer\u2019s treatments focus on beta-amyloid plaques, new research targets early-stage DNA damage and chronic neuroinflammation as critical drivers of the disease. In preclinical mouse models, the drug KCL-286 \u2014 a compound already proven safe in human spinal cord injury trials \u2014 successfully activated DNA repair genes, healed double-strand DNA breaks in neurons, and significantly reduced neuroinflammation. By addressing these foundational pathological processes, KCL-286 has the potential to slow Alzheimer\u2019s progression rather than merely managing symptoms, offering a promising candidate for early or even asymptomatic intervention. Additionally, the article highlights a separate breakthrough in late-stage care, noting that psilocybin successfully restored speech and motor control in a patient after a decade of battling the disease.<\/p>\n<hr>\n<p>A drug, that has previously been shown to be safe and tolerated by humans, reduces multiple disease-linked features of Alzheimer\u2019s in a mouse model of the disease.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>While most current Alzheimer\u2019s treatments focus on beta-amyloid plaques, new research targets early-stage DNA damage and chronic neuroinflammation as critical drivers of the disease. In preclinical mouse models, the drug KCL-286 \u2014 a compound already proven safe in human spinal cord injury trials \u2014 successfully activated DNA repair genes, healed double-strand DNA breaks in neurons, [\u2026]<\/p>\n","protected":false},"author":701,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-240561","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/240561","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/701"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=240561"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/240561\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=240561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=240561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=240561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}